Vetoquinol SA (EPA:VETO)
France · Delayed Price · Currency is EUR 72.40
+0.60 (0.84%)
At close: Nov 10, 2025
Vetoquinol Company Description
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region.
It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal medicine; and cardio-nephrology.
The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
Vetoquinol SA
| Country | France |
| Founded | 1933 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 2,501 |
| CEO | Matthieu Frechin |
Contact Details
Address: Magny-Vernois Lure, 70204 France | |
| Phone | 33 3 84 62 55 55 |
| Website | vetoquinol.com |
Stock Details
| Ticker Symbol | VETO |
| Exchange | Euronext Paris |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FR0004186856 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Alain Masson | Deputy Chief Executive Officer and Pharmacist Manager |
| Dominique Derveaux | Chief Operations Officer and Group Deputy Chief Executive Officer |
| Matthieu Frechin | Chief Executive Officer and Non-Independent Chairman of the Board |
| Regis Vimal du Monteil | Chief Financial Officer |
| Philippe Gruet | Chief Scientific Officer |
| Sandrine Perrier | Chief Information Officer |
| Laurent Thore | Director of Partnerships, Legal Affairs and Risks |
| Xavier Berthet | Director of Group Communications |
| Nathalie Arlecchini | Group Human Resources Director |